Original language | English |
---|---|
Pages (from-to) | S51-S52 |
Journal | Nuclear medicine and biology |
Volume | 96-97 |
Publication status | Published - 2021 |
Synthesis and preclinical evaluation of [methylpiperazine-C-11]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors
Antonia Hognasbacka, Esther Kooijman, Robert Schuit, Maxime Schreurs, Mariska Verlaan, Wissam Beaino, Danielle Vugts, Guus van Dongen, Alex Poot, Albert Windhorst
Research output: Contribution to journal › Meeting Abstract › Academic